{"id":"https://openalex.org/W2106239199","doi":"https://doi.org/10.1093/jac/dkt347","title":"Successful treatment of simulated Clostridium difficile infection in a human gut model by fidaxomicin first line and after vancomycin or metronidazole failure","display_name":"Successful treatment of simulated Clostridium difficile infection in a human gut model by fidaxomicin first line and after vancomycin or metronidazole failure","publication_year":2013,"publication_date":"2013-09-03","ids":{"openalex":"https://openalex.org/W2106239199","doi":"https://doi.org/10.1093/jac/dkt347","mag":"2106239199","pmid":"https://pubmed.ncbi.nlm.nih.gov/24003182"},"language":"en","primary_location":{"id":"doi:10.1093/jac/dkt347","doi":"https://doi.org/10.1093/jac/dkt347","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/dkt347","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069950437","display_name":"C. H. Chilton","orcid":"https://orcid.org/0000-0002-8076-1699","observed_orcids":["https://orcid.org/0000-0002-8076-1699"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C. H. Chilton","raw_affiliation_strings":["Leeds Institute for Molecular Medicine, University of Leeds, Leeds LS2 9JT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leeds Institute for Molecular Medicine, University of Leeds, Leeds LS2 9JT, UK","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050853055","display_name":"Grace S. Crowther","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G. S. Crowther","raw_affiliation_strings":["Leeds Institute for Molecular Medicine, University of Leeds, Leeds LS2 9JT, UK","1Leeds Institute for Molecular Medicine, University of Leeds, Leeds LS2 9JT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leeds Institute for Molecular Medicine, University of Leeds, Leeds LS2 9JT, UK","institution_ids":["https://openalex.org/I130828816"]},{"raw_affiliation_string":"1Leeds Institute for Molecular Medicine, University of Leeds, Leeds LS2 9JT, UK","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086749897","display_name":"Jane Freeman","orcid":"https://orcid.org/0000-0001-9580-4586","observed_orcids":["https://orcid.org/0000-0001-9580-4586"]},"institutions":[{"id":"https://openalex.org/I1295121038","display_name":"Leeds General Infirmary","ror":"https://ror.org/04hrjej96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1295121038","https://openalex.org/I2799390153"]},{"id":"https://openalex.org/I2799390153","display_name":"Leeds Teaching Hospitals NHS Trust","ror":"https://ror.org/00v4dac24","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799390153"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. Freeman","raw_affiliation_strings":["Department of Microbiology, Leeds Teaching Hospitals NHS Trust, The General Infirmary, Old Medical School, Leeds LS1 3EX, UK","2Department of Microbiology, Leeds Teaching Hospitals NHS Trust, The General Infirmary, Old Medical School, Leeds LS1 3EX, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology, Leeds Teaching Hospitals NHS Trust, The General Infirmary, Old Medical School, Leeds LS1 3EX, UK","institution_ids":["https://openalex.org/I1295121038","https://openalex.org/I2799390153"]},{"raw_affiliation_string":"2Department of Microbiology, Leeds Teaching Hospitals NHS Trust, The General Infirmary, Old Medical School, Leeds LS1 3EX, UK","institution_ids":["https://openalex.org/I1295121038","https://openalex.org/I2799390153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075702347","display_name":"Sharie L. Todhunter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S. L. Todhunter","raw_affiliation_strings":["Leeds Institute for Molecular Medicine, University of Leeds, Leeds LS2 9JT, UK","1Leeds Institute for Molecular Medicine, University of Leeds, Leeds LS2 9JT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leeds Institute for Molecular Medicine, University of Leeds, Leeds LS2 9JT, UK","institution_ids":["https://openalex.org/I130828816"]},{"raw_affiliation_string":"1Leeds Institute for Molecular Medicine, University of Leeds, Leeds LS2 9JT, UK","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":null,"display_name":"S. Nicholson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S. Nicholson","raw_affiliation_strings":["Leeds Institute for Molecular Medicine, University of Leeds, Leeds LS2 9JT, UK","1Leeds Institute for Molecular Medicine, University of Leeds, Leeds LS2 9JT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leeds Institute for Molecular Medicine, University of Leeds, Leeds LS2 9JT, UK","institution_ids":["https://openalex.org/I130828816"]},{"raw_affiliation_string":"1Leeds Institute for Molecular Medicine, University of Leeds, Leeds LS2 9JT, UK","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016916593","display_name":"Christopher M. Longshaw","orcid":"https://orcid.org/0000-0002-5586-7256","observed_orcids":["https://orcid.org/0000-0002-5586-7256"]},"institutions":[{"id":"https://openalex.org/I4210102929","display_name":"Astellas Pharma (United Kingdom)","ror":"https://ror.org/018788w33","country_code":"GB","type":"company","lineage":["https://openalex.org/I142395110","https://openalex.org/I4210102929"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C. M. Longshaw","raw_affiliation_strings":["Astellas Pharma Europe Ltd, 2000 Hillswood Drive, Chertsey, Surrey KT16 0RS, UK","3Astellas Pharma Europe Ltd, 2000 Hillswood Drive, Chertsey, Surrey KT16 0RS, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astellas Pharma Europe Ltd, 2000 Hillswood Drive, Chertsey, Surrey KT16 0RS, UK","institution_ids":["https://openalex.org/I4210102929"]},{"raw_affiliation_string":"3Astellas Pharma Europe Ltd, 2000 Hillswood Drive, Chertsey, Surrey KT16 0RS, UK","institution_ids":["https://openalex.org/I4210102929"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027928189","display_name":"Mark H. Wilcox","orcid":"https://orcid.org/0000-0002-4565-2868","observed_orcids":["https://orcid.org/0000-0002-4565-2868"]},"institutions":[{"id":"https://openalex.org/I1295121038","display_name":"Leeds General Infirmary","ror":"https://ror.org/04hrjej96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1295121038","https://openalex.org/I2799390153"]},{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]},{"id":"https://openalex.org/I2799390153","display_name":"Leeds Teaching Hospitals NHS Trust","ror":"https://ror.org/00v4dac24","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799390153"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"M. H. Wilcox","raw_affiliation_strings":["Department of Microbiology, Leeds Teaching Hospitals NHS Trust, The General Infirmary, Old Medical School, Leeds LS1 3EX, UK","Leeds Institute for Molecular Medicine, University of Leeds, Leeds LS2 9JT, UK","1Leeds Institute for Molecular Medicine, University of Leeds, Leeds LS2 9JT, UK","2Department of Microbiology, Leeds Teaching Hospitals NHS Trust, The General Infirmary, Old Medical School, Leeds LS1 3EX, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology, Leeds Teaching Hospitals NHS Trust, The General Infirmary, Old Medical School, Leeds LS1 3EX, UK","institution_ids":["https://openalex.org/I1295121038","https://openalex.org/I2799390153"]},{"raw_affiliation_string":"Leeds Institute for Molecular Medicine, University of Leeds, Leeds LS2 9JT, UK","institution_ids":["https://openalex.org/I130828816"]},{"raw_affiliation_string":"1Leeds Institute for Molecular Medicine, University of Leeds, Leeds LS2 9JT, UK","institution_ids":["https://openalex.org/I130828816"]},{"raw_affiliation_string":"2Department of Microbiology, Leeds Teaching Hospitals NHS Trust, The General Infirmary, Old Medical School, Leeds LS1 3EX, UK","institution_ids":["https://openalex.org/I1295121038","https://openalex.org/I2799390153"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5027928189"],"corresponding_institution_ids":["https://openalex.org/I1295121038","https://openalex.org/I130828816","https://openalex.org/I2799390153"],"apc_list":{"value":2869,"currency":"GBP","value_usd":3784},"apc_paid":null,"fwci":5.2163,"has_fulltext":true,"cited_by_count":51,"citation_normalized_percentile":{"value":0.96112181,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"69","issue":"2","first_page":"451","last_page":"462"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11288","display_name":"Clostridium difficile and Clostridium perfringens research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11288","display_name":"Clostridium difficile and Clostridium perfringens research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10066","display_name":"Gut microbiota and health","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12167","display_name":"Bacterial Identification and Susceptibility Testing","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clostridium-difficile-infection","display_name":"Clostridium difficile infection","score":0.9940000176429749},{"id":"https://openalex.org/keywords/fidaxomicin","display_name":"fidaxomicin","score":0.9929999709129333},{"id":"https://openalex.org/keywords/vancomycin","display_name":"vancomycin","score":0.8349999785423279},{"id":"https://openalex.org/keywords/metronidazole","display_name":"metronidazole","score":1.0},{"id":"https://openalex.org/keywords/recurrent-clostridioides-difficile-infection","display_name":"recurrent Clostridium difficile infection","score":0.8820000290870667},{"id":"https://openalex.org/keywords/chemostat","display_name":"chemostat","score":0.6840000152587891},{"id":"https://openalex.org/keywords/toxin-production","display_name":"toxin production","score":0.5479999780654907},{"id":"https://openalex.org/keywords/spore-counts","display_name":"spore counts","score":0.6269999742507935},{"id":"https://openalex.org/keywords/gut-microbiota","display_name":"gut microbiota","score":0.7749999761581421},{"id":"https://openalex.org/keywords/bifidobacterium","display_name":"Bifidobacterium","score":0.871999979019165},{"id":"https://openalex.org/keywords/treatment-failure","display_name":"treatment failure","score":0.30799999833106995}],"concepts":[{"id":"https://openalex.org/C2781342628","wikidata":"https://www.wikidata.org/wiki/Q5446672","display_name":"Fidaxomicin","level":5,"score":0.976983904838562},{"id":"https://openalex.org/C2994496256","wikidata":"https://www.wikidata.org/wiki/Q27031090","display_name":"Clostridium difficile","level":3,"score":0.9149520397186279},{"id":"https://openalex.org/C2778980435","wikidata":"https://www.wikidata.org/wiki/Q424027","display_name":"Vancomycin","level":4,"score":0.8555995225906372},{"id":"https://openalex.org/C2777396551","wikidata":"https://www.wikidata.org/wiki/Q169569","display_name":"Metronidazole","level":3,"score":0.8475463390350342},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.6393653750419617},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.580070972442627},{"id":"https://openalex.org/C2776258884","wikidata":"https://www.wikidata.org/wiki/Q3055368","display_name":"Enterocolitis","level":2,"score":0.437730073928833},{"id":"https://openalex.org/C2909981330","wikidata":"https://www.wikidata.org/wiki/Q857288","display_name":"Gram-positive bacterial infections","level":3,"score":0.42216819524765015},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.3999093770980835},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2736835777759552},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2581009268760681},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.17698699235916138},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D003015","descriptor_name":"Clostridium Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003015","descriptor_name":"Clostridium Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008795","descriptor_name":"Metronidazole","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D014640","descriptor_name":"Vancomycin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016360","descriptor_name":"Clostridioides difficile","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016360","descriptor_name":"Clostridioides difficile","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017211","descriptor_name":"Treatment Failure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D041981","descriptor_name":"Gastrointestinal Tract","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D041981","descriptor_name":"Gastrointestinal Tract","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1093/jac/dkt347","doi":"https://doi.org/10.1093/jac/dkt347","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/dkt347","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},{"id":"pmid:24003182","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24003182","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of antimicrobial chemotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:open-archive.highwire.org:jac:dkt347v1","doi":null,"is_oa":false,"landing_page_url":"http://jac.oxfordjournals.org/cgi/content/short/dkt347v1","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320323599","display_name":"Astellas Pharma Europe","ror":"https://ror.org/018788w33"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1592764992","https://openalex.org/W1988460456","https://openalex.org/W2005877606","https://openalex.org/W2008549364","https://openalex.org/W2014488080","https://openalex.org/W2025934522","https://openalex.org/W2035313996","https://openalex.org/W2066447793","https://openalex.org/W2089018302","https://openalex.org/W2095874856","https://openalex.org/W2096284531","https://openalex.org/W2104403177","https://openalex.org/W2105510659","https://openalex.org/W2106310075","https://openalex.org/W2113556993","https://openalex.org/W2123265098","https://openalex.org/W2123366827","https://openalex.org/W2123776003","https://openalex.org/W2128337013","https://openalex.org/W2144282350","https://openalex.org/W2149642295","https://openalex.org/W2150612866","https://openalex.org/W2150765371","https://openalex.org/W2167016769","https://openalex.org/W2169529718","https://openalex.org/W2170699724"],"related_works":["https://openalex.org/W1903816608","https://openalex.org/W1892415719","https://openalex.org/W2104815174","https://openalex.org/W2170699724","https://openalex.org/W2149642295","https://openalex.org/W4396699811","https://openalex.org/W3099304434","https://openalex.org/W7099006970","https://openalex.org/W4294495120","https://openalex.org/W2144282350"],"abstract_inverted_index":{"OBJECTIVES:":[0],"Fidaxomicin":[1,99,178,189,207,215],"reduces":[2],"the":[3,107,160,184,247],"risk":[4],"of":[5,39,109,172,235],"recurrent":[6,213],"Clostridium":[7],"difficile":[8,77],"infection":[9],"(CDI)":[10],"compared":[11],"with":[12,34,118,169],"vancomycin.":[13],"We":[14],"investigated":[15],"fidaxomicin":[16,41,67,154],"primary":[17,211],"or":[18,52,129,175,243],"secondary":[19],"treatment":[20],"efficacy":[21],"using":[22],"a":[23,180],"gut":[24,30,89,248],"model.":[25],"METHODS:":[26],"Four":[27],"triple-stage":[28],"chemostat":[29],"models":[31],"were":[32,95,201],"inoculated":[33],"faeces.":[35],"After":[36],"clindamycin":[37],"induction":[38],"CDI,":[40],"(200":[42,68],"mg/L":[43,48,55,69],"twice":[44,70],"daily),":[45],"vancomycin":[46,151,229,242],"(125":[47],"four":[49],"times":[50,57],"daily)":[51,58],"metronidazole":[53,219],"(9.3":[54],"three":[56],"was":[59,74,166,190,216],"administered":[60],"for":[61,187,192,250],"7":[62,72],"days.":[63,205],"Following":[64],"failure/CDI":[65],"recurrence,":[66],"daily,":[71],"days)":[73],"instilled.":[75],"C.":[76],"(CD)":[78],"total":[79],"viable":[80],"counts":[81,84,91],"(TVC),":[82],"spore":[83,173],"(SP),":[85],"toxin":[86,176],"titres":[87],"(CYT),":[88],"bacteria":[90],"and":[92,104,114,136,212,224,226],"antimicrobial":[93],"concentrations":[94],"measured":[96],"throughout.":[97],"RESULTS:":[98],"instillation":[100,123,132,155],"reduced":[101,133,156],"CD":[102,127,134,157,165,222],"TVC/SP":[103],"CYT":[105,137],"below":[106,159],"limit":[108],"detection":[110],"(LOD)":[111],"after":[112,150,253],"2":[113],"4":[115],"days,":[116],"respectively,":[117],"no":[119,170],"CDI":[120],"recurrence.":[121],"Metronidazole":[122],"failed":[124],"to":[125,138,218,228],"decrease":[126],"TVC":[128,135,223],"CYT.":[130],"Vancomycin":[131],"LOD":[139,161],"by":[140],"day":[141,163],"4,":[142],"but":[143,240],"SP":[144,232],"persisted.":[145],"Recurrence":[146],"occurred":[147],"13":[148],"days":[149,196,252],"instillation;":[152],"subsequent":[153],"TVC/SP/CYT":[158],"from":[162],"2.":[164],"isolated":[167],"sporadically,":[168],"evidence":[171],"recrudescence":[174],"production.":[177],"had":[179],"minimal":[181],"effect":[182],"on":[183],"microflora,":[185],"except":[186],"bifidobacteria.":[188],"detected":[191],"at":[193],"least":[194],"21":[195],"post-instillation,":[197],"whereas":[198],"other":[199],"antimicrobials":[200],"undetectable":[202],"beyond":[203],"\u223c4":[204],"CONCLUSIONS:":[206],"successfully":[208],"treated":[209],"simulated":[210],"CDI.":[214],"superior":[217,227],"in":[220,230,246],"reducing":[221,231],"SP,":[225],"without":[233],"recurrence":[234],"vegetative":[236],"cell":[237],"growth.":[238],"Fidaxomicin,":[239],"not":[241],"metronidazole,":[244],"persisted":[245],"model":[249],">20":[251],"instillation.":[254]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}